drugset / Trial / NCT06841445
Efficacy and Safety of HRS9531 Tablet in Obese Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy of HRS9531 tablet compared with placebo in reducing body weight in obese subjects after 26 weeks of treatment.
Timeline
- Start
- 2025-04-07
- Primary completion
- 2026-01-08
- Completion
- 2026-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS9531 | Unknown | — | — |
Indications
No indication recorded.